Topical Application of a Vitamin A Derivative and Its Combination With Non-ablative Fractional Laser Potentiates Cutaneous Influenza Vaccination.
Topical Application of a Vitamin A Derivative and Its Combination With Non-ablative Fractional Laser Potentiates Cutaneous Influenza Vaccination.
复制标题
DOI:
10.3389/fmicb.2018.02570
复制
发表时间:
2018
影响因子:
5.2
通讯作者:
Lu L
中科院分区:
文献类型:
--
作者:
Li P;Wang J;Cao M;Deng Q;Jiang S;Wu MX;Lu L
Skin contains a large number of antigen presenting cells, making intradermal (ID) injection one of the most effective ways for vaccine administration. However, although current adjuvants may cause severe local reactions and inflammations in the skin, no adjuvant has been approved for ID vaccination so far. Here, we report that topical application of all-trans retinoic acid (ATRA), a vitamin A derivative produced in the human body, augmented cutaneous influenza vaccination. The adjuvant effects were evaluated in a murine vaccination/challenge model by using A/California/07/2009 pandemic vaccine (09V) or a seasonal influenza vaccine (SIV). ATRA drove a Th2-biased immune response, as demonstrated by profoundly elevated IgG1 titer rather than IgG2 titer. Combining ATRA with a non-ablative fractional laser (NAFL), which represents a new category of vaccine adjuvant utilizing physical stimuli to induce self-immune stimulators, further enhanced the efficacy of influenza vaccines with a more balanced Th1/Th2 immune response. The dual adjuvant strengthened cross-reactive immune responses against both homogenous and heterogeneous influenza viral strains. Analysis of gene expression profile showed that ATRA/NAFL stimulated upregulation of cytosolic nucleic acid sensors and their downstream factors, leading to a synergistic elevation of type I interferon expression. Consistent with this finding, knocking out IRF3 or IRF7, two key downstream regulatory factors in most nucleic acid sensing pathways, resulted in a significant decrease in the adjuvant effect of ATRA/NAFL. Thus, our study demonstrates that the self molecule ATRA could boost cutaneous influenza vaccination either alone or ideally in combination with NAFL.
登录
查看更多内容
影响因子:
3.7
作者:
Kumar S;Quinn SC;Kim KH;Hilyard KM
通讯作者:
Hilyard KM
影响因子:
8
作者:
Hashimoto-Hill S;Friesen L;Kim M;Kim CH
通讯作者:
Kim CH
影响因子:
7.2
作者:
Galvez-Cancino, Felipe;Lopez, Ernesto;Lladser, Alvaro
通讯作者:
Lladser, Alvaro
DOI:
10.1158/1078-0432.ccr-11-2654
发表时间:
2012-04-15
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Chen X;Zeng Q;Wu MX
通讯作者:
Wu MX
影响因子:
32.4
作者:
Hall JA;Grainger JR;Spencer SP;Belkaid Y
通讯作者:
Belkaid Y